PERFORMANT HEALTHCARE INC (PHLT) Fundamental Analysis & Valuation

NASDAQ:PHLT • US71377E1055

Current stock price

7.75 USD
+0.02 (+0.26%)
At close:
7.75 USD
0 (0%)
After Hours:

This PHLT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. PHLT Profitability Analysis

1.1 Basic Checks

  • In the past year PHLT has reported negative net income.
  • In the past year PHLT had a positive cash flow from operations.
  • In the past 5 years PHLT always reported negative net income.
  • PHLT had a positive operating cash flow in 4 of the past 5 years.
PHLT Yearly Net Income VS EBIT VS OCF VS FCFPHLT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

1.2 Ratios

  • The Return On Assets of PHLT (-0.80%) is comparable to the rest of the industry.
  • PHLT has a Return On Equity (-1.08%) which is comparable to the rest of the industry.
  • PHLT's Return On Invested Capital of 0.19% is on the low side compared to the rest of the industry. PHLT is outperformed by 60.40% of its industry peers.
Industry RankSector Rank
ROA -0.8%
ROE -1.08%
ROIC 0.19%
ROA(3y)-7.6%
ROA(5y)-8.46%
ROE(3y)-9.98%
ROE(5y)-15.16%
ROIC(3y)N/A
ROIC(5y)N/A
PHLT Yearly ROA, ROE, ROICPHLT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

  • The Operating Margin of PHLT (0.16%) is worse than 60.40% of its industry peers.
  • The Profit Margin and Gross Margin are not available for PHLT so they could not be analyzed.
Industry RankSector Rank
OM 0.16%
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PHLT Yearly Profit, Operating, Gross MarginsPHLT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 -10 -15

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. PHLT Health Analysis

2.1 Basic Checks

  • PHLT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for PHLT has been increased compared to 1 year ago.
  • The number of shares outstanding for PHLT has been increased compared to 5 years ago.
  • PHLT has a worse debt/assets ratio than last year.
PHLT Yearly Shares OutstandingPHLT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
PHLT Yearly Total Debt VS Total AssetsPHLT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • An Altman-Z score of 13.67 indicates that PHLT is not in any danger for bankruptcy at the moment.
  • PHLT's Altman-Z score of 13.67 is amongst the best of the industry. PHLT outperforms 95.05% of its industry peers.
  • PHLT has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.10, PHLT is in the better half of the industry, outperforming 77.23% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Altman-Z 13.67
ROIC/WACC0.02
WACC9.27%
PHLT Yearly LT Debt VS Equity VS FCFPHLT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M

2.3 Liquidity

  • A Current Ratio of 2.64 indicates that PHLT has no problem at all paying its short term obligations.
  • With an excellent Current ratio value of 2.64, PHLT belongs to the best of the industry, outperforming 82.18% of the companies in the same industry.
  • PHLT has a Quick Ratio of 2.64. This indicates that PHLT is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of PHLT (2.64) is better than 82.18% of its industry peers.
Industry RankSector Rank
Current Ratio 2.64
Quick Ratio 2.64
PHLT Yearly Current Assets VS Current LiabilitesPHLT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. PHLT Growth Analysis

3.1 Past

  • PHLT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 87.50%, which is quite impressive.
  • The Revenue has grown by 15.21% in the past year. This is quite good.
  • PHLT shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -3.95% yearly.
EPS 1Y (TTM)87.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%175%
Revenue 1Y (TTM)15.21%
Revenue growth 3Y-0.38%
Revenue growth 5Y-3.95%
Sales Q2Q%28.75%

3.2 Future

  • Based on estimates for the next years, PHLT will show a very strong growth in Earnings Per Share. The EPS will grow by 50.55% on average per year.
  • PHLT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.37% yearly.
EPS Next Y89.54%
EPS Next 2Y60.48%
EPS Next 3Y50.55%
EPS Next 5YN/A
Revenue Next Year10.75%
Revenue Next 2Y10.42%
Revenue Next 3Y11.37%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
PHLT Yearly Revenue VS EstimatesPHLT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
PHLT Yearly EPS VS EstimatesPHLT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2021 2022 2023 2024 2025 2026 2027 0 -0.2 -0.4

More info and screens

Find the best growth stocksShow best growing peers

1

4. PHLT Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for PHLT. In the last year negative earnings were reported.
  • PHLT is valuated quite expensively with a Price/Forward Earnings ratio of 103.61.
  • Based on the Price/Forward Earnings ratio, PHLT is valued a bit more expensive than the industry average as 60.40% of the companies are valued more cheaply.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.12, PHLT is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 103.61
PHLT Price Earnings VS Forward Price EarningsPHLT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -200 -400 -600

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PHLT indicates a slightly more expensive valuation: PHLT is more expensive than 62.38% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 96.91
PHLT Per share dataPHLT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • PHLT's earnings are expected to grow with 50.55% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y60.48%
EPS Next 3Y50.55%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PHLT Dividend Analysis

5.1 Amount

  • No dividends for PHLT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

PHLT Fundamentals: All Metrics, Ratios and Statistics

PERFORMANT HEALTHCARE INC

NASDAQ:PHLT (10/20/2025, 8:10:13 PM)

After market: 7.75 0 (0%)

7.75

+0.02 (+0.26%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-07
Earnings (Next)11-11
Inst Owners88.43%
Inst Owner ChangeN/A
Ins Owners5.34%
Ins Owner ChangeN/A
Market Cap623.41M
Revenue(TTM)137.36M
Net Income(TTM)-885.00K
Analysts48.89
Price Target7.91 (2.06%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)188.22%
Min EPS beat(2)100%
Max EPS beat(2)276.44%
EPS beat(4)4
Avg EPS beat(4)104.9%
Min EPS beat(4)1.96%
Max EPS beat(4)276.44%
EPS beat(8)8
Avg EPS beat(8)102.34%
EPS beat(12)11
Avg EPS beat(12)79.64%
EPS beat(16)14
Avg EPS beat(16)64.19%
Revenue beat(2)2
Avg Revenue beat(2)10.95%
Min Revenue beat(2)9%
Max Revenue beat(2)12.91%
Revenue beat(4)2
Avg Revenue beat(4)4.88%
Min Revenue beat(4)-2.19%
Max Revenue beat(4)12.91%
Revenue beat(8)6
Avg Revenue beat(8)3.99%
Revenue beat(12)7
Avg Revenue beat(12)1.42%
Revenue beat(16)10
Avg Revenue beat(16)2.44%
PT rev (1m)0%
PT rev (3m)6.9%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-300.3%
EPS NY rev (1m)0%
EPS NY rev (3m)-188.87%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.01%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.25%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 103.61
P/S 4.54
P/FCF N/A
P/OCF 129.71
P/B 7.58
P/tB 17.88
EV/EBITDA 96.91
EPS(TTM)-0.01
EYN/A
EPS(NY)0.07
Fwd EY0.97%
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0.06
OCFY0.77%
SpS1.71
BVpS1.02
TBVpS0.43
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.8%
ROE -1.08%
ROCE 0.24%
ROIC 0.19%
ROICexc 0.21%
ROICexgc 0.48%
OM 0.16%
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-7.6%
ROA(5y)-8.46%
ROE(3y)-9.98%
ROE(5y)-15.16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover1.24
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Debt/EBITDA 1.25
Cap/Depr 84.63%
Cap/Sales 3.82%
Interest Coverage 0.27
Cash Conversion 74.84%
Profit Quality N/A
Current Ratio 2.64
Quick Ratio 2.64
Altman-Z 13.67
F-Score6
WACC9.27%
ROIC/WACC0.02
Cap/Depr(3y)88.51%
Cap/Depr(5y)80.81%
Cap/Sales(3y)4.21%
Cap/Sales(5y)3.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)87.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%175%
EPS Next Y89.54%
EPS Next 2Y60.48%
EPS Next 3Y50.55%
EPS Next 5YN/A
Revenue 1Y (TTM)15.21%
Revenue growth 3Y-0.38%
Revenue growth 5Y-3.95%
Sales Q2Q%28.75%
Revenue Next Year10.75%
Revenue Next 2Y10.42%
Revenue Next 3Y11.37%
Revenue Next 5YN/A
EBIT growth 1Y104.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year212.29%
EBIT Next 3Y72.41%
EBIT Next 5YN/A
FCF growth 1Y-183.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1.31%
OCF growth 3Y88.66%
OCF growth 5YN/A

PERFORMANT HEALTHCARE INC / PHLT Fundamental Analysis FAQ

What is the ChartMill fundamental rating of PERFORMANT HEALTHCARE INC (PHLT) stock?

ChartMill assigns a fundamental rating of 3 / 10 to PHLT.


What is the valuation status for PHLT stock?

ChartMill assigns a valuation rating of 1 / 10 to PERFORMANT HEALTHCARE INC (PHLT). This can be considered as Overvalued.


What is the profitability of PHLT stock?

PERFORMANT HEALTHCARE INC (PHLT) has a profitability rating of 1 / 10.